SEI Investments’s Structure Therapeutics GPCR Stock Holding History

SEI Investments’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$517K	Buy	16,548 +2,864	+21%	+$134K	﹤0.01%	2623
2026 Q2	$734K	Sell	13,684 -306	-2%	-$13.5K	﹤0.01%	2467
2026 Q1	$674K	Sell	13,990 -913	-6%	-$62.5K	﹤0.01%	2547
2025 Q4	$1.04M	Buy	+14,903	New	+$608K	﹤0.01%	2164
2024 Q3	–	Sell	-5,395	Closed	-$212K	–	2716
2024 Q2	$212K	Buy	+5,395	New	+$222K	﹤0.01%	2441

Other funds holding GPCR

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Capitolis Liquid Global Markets New York $22.4B AUM 40.52% 1-Year Est. Return

Pacific Heights Asset Management San Francisco, California $3.1B AUM 37.54% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

SEB Asset Management Stockholm $27B AUM

SEI Investments's GPCR Position: Q3 2026 in Review

SEI Investments increased its Structure Therapeutics (GPCR) stake by 21% in Q3 2026, buying an estimated $134K and bringing the position to 16,548 shares worth $517K. The position accounts for ﹤0.01% of the portfolio, ranked #2623.

SEI Investments first reported a position in GPCR in Q2 2024 and has held it in 5 quarters since. The position peaked at $1.04M in Q4 2025. 88 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.

SEI Investments held 16,548 shares of Structure Therapeutics worth $517K as of Q3 2026.
SEI Investments bought 2,864 Structure Therapeutics shares in Q3 2026, an estimated $134K.
Structure Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2623 holding.
SEI Investments first reported a position in Structure Therapeutics in Q2 2024 and has held it in 5 quarters since.
SEI Investments's Structure Therapeutics position peaked at $1.04M in Q4 2025.
88 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.